Bugworks one of four global companies exemplified in this latest AMR report from Access to Medicines Foundation
G7 health ministers make AMR an important facet of pandemic preparedness and vow to incentivise this space
Bugworks featured amongst the top 5 innovative Biotech companies to look out for in India by Pharmareg News.
Bugworks secures support from US Government's Defense Threat Reduction Agency (DTRA) to validate its clinical asset against the toughest bacterial biothreats
Dr. Oppel Greeff, Bugworks’ investor and member of SAB, wins the prestigious Havengaprize by the South Africa Academy of Art and Science
Bugworks’ CEO interviewed by the Financial Express as part of a story done on World innovation day!
Anand Anandkumar, Bugworks’ CEO has been re-nominated into the Board of AMR Industry Alliance and will serve as key member of the Biotech Working Group within this global alliance.
Anand Anandkumar has been selected by CEO Insights Magazine for 'Top 10 Best Leaders in Biotechnology in India 2021'
Bugworks on BBC’s people fixing the world podcast.
Bugworks Research, one of the three companies to be showcased in GlobalBioIndia event 2021.
Japanese venture company UTEC - The University of Tokyo Edge Capital Partners is enabling world class innovation from India in lifesciences - Bugworks Research Inc. as an exemplar!
ALCOR Fund has chosen Bugworks as one of top 10 most innovative biotech startups in India
Bugworks showcased as pioneering start-up in Indian biotech, attracting global funding.
Dr.Anand Anandkumar Co-Founder and CEO of Bugworks Research Inc. has been inducted into Basel area innovation India Board (BIIB).
